Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Go to hell

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Jul 10, 2022 12:09pm

143 Views

Post# 34813779

RE:RE:RE:RE:RE:RE:RE:RE:Go to hell

Hate smart women are you for real?! I actually have spoke to her and find her quite pleasant i just dont feel she is wanting to do anything different from what past efforts were in ir. Im done bantering with you. Clearly you have some sort of agenda other than investment.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia